Glycogen synthase kinase-3 – a promising therapeutic target: interview with Hagit Eldar-Finkelman

Author： Quigley Emma  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.2, 2006-04, pp. : 199-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physiological Roles of Glycogen Synthase Kinase-3: Potential as a Therapeutic Target for Diabetes and Other Disorders

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 281-290

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: GSK-3 in Health and Disease (Guest Editor: H. Eldar-Finkelman)]

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1375-1375

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1421-1434

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Roles for Glycogen Synthase Kinase-3 as a Drug Target in Alzheimer's Disease

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1389-1397

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite